Ranbaxy moves court to halt Elder's 'ride' on pain-reliever brand Volini
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has initiated legal action against Elder Pharmaceuticals charging the latter with deliberately trying to "ride" on its reputation in a case concerning Ranbaxy's top-selling OTC topical pain-reliever brand, Volini.
You may also be interested in...
Sun Wards Off Volini Infringers, Makes It Count Too
Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini – among the key products at the core of the Indian firm’s OTC business.
Sun Wards Off Volini Infringers, Makes It Count Too
Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini – among the key products at the core of the Indian firm’s OTC business.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.